Sort
30,917 grants matching “tumor microenvironment”
Dissecting the interplay between aging, genotype and the microenvironment in lung cancer
$471,751Monte Meier Winslow · Stanford University · U01 · FY2022 · AG
Targeting AVIL in Glioblastoma
$471,746Hui Li · University Of Virginia · R01 · FY2024 · CA
Targeting glycocalyx-mediated mechanisms of tumor metastasis
$471,731Lance L Munn · Massachusetts General Hospital · R01 · FY2017 · CA
A First-in-Class FAP-activated Protoxin to disrupt the Tumor-Stroma Parasitic Cycle fueling lethal Prostate Cancer Progression
$471,718William Nathaniel Brennen · Johns Hopkins University · R01 · FY2021 · CA
Investigating the Role of Emergent Oscillations of Hypoxia Inducible Factor-1 alpha Activity in Cancer Growth and Progression
$471,661Fnu Kshitiz · University Of Connecticut Sch Of Med/Dnt · R37 · FY2024 · CA
Neural Niche in Promoting Brain Metastatic Tumor Progression
$471,652Siyuan Zhang · University Of Notre Dame · R01 · FY2021 · CA
Project 3: Transcriptomic subtypes, response predictions, and therapy selection
$471,647Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2022 · CA
Co-evolution of the Reactive Microenvironment in Prostate Cancer Progression
$471,453David R Rowley · Baylor College Of Medicine · U54 · FY2010 · CA
DEVELOPMENTAL FUNDS
$471,426Paul A Bunn · University Of Colorado Denver · P30 · FY2016 · CA
Targeting innate immune pathways in breast cancers with chromosomal instability
$471,423Samuel F Bakhoum · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Improving efficacy of radioiodine treatment of thyroid cancer
$471,416James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Improving efficacy of radioiodine treatment of thyroid cancer
$471,416James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Function of IL35+ B cells in pancreatic cancer
$471,387Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2020 · CA
Role of autophagy in the tumor microenvironment
$471,376Sufi Mary Thomas · University Of Kansas Medical Center · R01 · FY2022 · CA
Changing Contraceptive Patterns and Ovarian Cancer Risk
$471,307Kathryn L Terry · Brigham And Women'S Hospital · R01 · FY2024 · CA
Hyaluronan Receptors in Prostate Cancer Progression
$471,291James B. McCarthy · University Of Minnesota · R01 · FY2009 · CA
Negative regulation of myeloid-derived suppressive cells in cancer
$471,244Yulia Nefedova · Wistar Institute · R01 · FY2021 · CA
Phenotype Interactions and Dynamics in SCLC Tumors
$471,194Alissa M Weaver · Vanderbilt University · U54 · FY2019 · CA
The role of Interleukin 17RB signaling in colorectal cancer progression
$471,181Sergei I Grivennikov · Cedars-Sinai Medical Center · R01 · FY2022 · CA
Engineering Nanomaterials to Prime Immunity
$471,122James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Drug-Loaded Nanobubbles for Ultrasound Enhanced Delivery to Colon Cancer Liver Metastasis
$471,119Agata A Exner · Case Western Reserve University · R01 · FY2021 · EB
Developing new therapeutic strategies against head and neck cancer
$471,077Ratna B Ray · Saint Louis University · R01 · FY2024 · DE
Role of EphB4-ephrin-B2 interaction in regulating crosstalk between cancer cell and vascular tumor microenvironment in head and neck cancer
$471,009Sana D Karam · University Of Colorado Denver · R01 · FY2022 · DE
Overcoming vaccine-associated hypoxia with advanced biomaterials to enhance cancer immunotherapy
$471,003Sidi A Bencherif · Northeastern University · R01 · FY2022 · EB
Systemic Delivery of Targeted Bi-Compartmental Nanoparticles for Glioblastoma Therapeutics
$470,970Joerg Lahann · University Of Michigan At Ann Arbor · R01 · FY2025 · NS